Centre Hospitalier Public Du Cotentin
- Address
- lock Available on a paid plan
Cardiovascular Diseases and Critical Care Research
At Centre Hospitalier Public Du Cotentin, clinical trials in cardiovascular diseases focus on serious heart and circulation problems, including cardiac arrest, atrial fibrillation, heart failure, and recovery after percutaneous coronary intervention. The studies are designed to test new treatment approaches, improve survival, and reduce complications in high-risk patients.
- Therapies for post-resuscitation care after cardiac arrest
- Strategies to prevent recurrent atrial fibrillation
- Approaches to improve outcomes after acute myocardial infarction and coronary procedures
These trials aim to refine treatment effectiveness and support better recovery for patients with complex cardiovascular conditions.
Respiratory Tract Diseases and Infectious Disease Studies
Research in respiratory tract diseases and bacterial infections includes work on chronic obstructive pulmonary disease and septic shock. The site is evaluating ways to improve symptom control, lower mortality, and strengthen care for critically ill patients.
- Testing new combinations for COPD symptom and outcome improvement
- Evaluating supportive treatments in septic shock
- Exploring options to reduce complications in severe infection-related illness
This area brings together critical care and respiratory medicine with a focus on practical treatment benefit.
Neoplasms and Oncology
The oncology department at Centre Hospitalier Public Du Cotentin is active in trials on breast cancer, colon cancer, and pancreatic adenocarcinoma. These studies are aimed at improving disease-free survival, refining adjuvant treatment choices, and identifying more effective cancer care for patients at different stages of disease.
- Testing add-on treatment to reduce relapse risk in ER+ and HER2- breast cancer
- Using circulating tumor DNA to guide colon cancer treatment decisions
- Comparing treatment options for advanced pancreatic cancer
These trials reflect a strong focus on personalized cancer treatment and better long-term outcomes.
Digestive System Diseases and Musculoskeletal Research
Clinical research in digestive system diseases and musculoskeletal diseases includes studies of colon carcinoma and gout. The main goals are to improve relapse prevention, ease symptoms, and compare treatment timing or strategy in common but impactful conditions.
- Optimizing care after colon cancer surgery
- Testing earlier treatment for gout
- Assessing longer-term control of disease recurrence
These trials combine everyday clinical questions with efforts to improve treatment effectiveness in gastrointestinal and joint-related disorders.
Other Specialized Research Areas
The site also conducts studies in reproductive and urinary physiological phenomena and other complex clinical settings, including patients with chronic kidney disease on peritoneal dialysis. This research often overlaps with cardiovascular care, focusing on safer treatment choices and better management of patients with multiple health problems.
- Evaluating safer anticoagulation options in dialysis patients
- Improving treatment decisions in patients with overlapping cardiac and kidney conditions
- Supporting care for patients with complicated chronic illness
Overall, the research portfolio at Centre Hospitalier Public Du Cotentin shows a broad interest in real-world treatment improvement across oncology, cardiology, infectious disease, and respiratory medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 15 of 37 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Public Du Cotentin
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter randomized trial to evaluate the efficacy of pioglitazone to promote renal tolerance in ANCA-associated vasculitis - RENATO | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 37 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 4 | Unknown | 2021-07-18 | 2024-10-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.